SMi Group are proud to announce the 9th Annual Orphan Drugs and Rare Diseases Conference, taking place on the 15th and 16th October 2019 in London, UK. The orphan drug market is continuously growing and is expected to reach $176 billion by 2020, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020). By 2020, orphan drugs are set to account for 19% of global prescription sales. This is due to the arising interest from pharmaceutical companies for underlying benefits, such as the potential discovery of mechanisms for more common diseases, and also the involvement of many smaller biotechnology start-up companies who are primarily focused on rare diseases.
The 2019 agenda features various key presentations by leading solution providers, biotechnology companies, clinical researchers, regulatory professionals and charity leaders discussing possible ways to accelerate orphan drug development and access to rare disease patients, including the introduction of recent technologies and products to help aid the access of orphan drugs.more
Arrange meetings with companies at
SMi’s 9th Annual Orphan Drugs & Rare Diseases Conference
No attending suppliers listed at the moment. Be the first one to list your company here.
- International Physicists Conference on Optics, Photonics and Laser Technology Planning committee of "International Physicists Conference on Opt...
- Pentagon City, Survival Skills for Todays Gynecologist CME Course 2019 Fall Want to make a decent and honest living as a gynecologist? This p...